ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT OCTOBER 2025

Zinzino group revenue increased with a total of 65 %, compared with the previous year.

The revenue in October for Zinzino's sales markets increased by 70 % and amounted to SEK 324.8 (191.6) million. Faun Pharma's external sales decreased and amounted to SEK 2.7 (7.3) million. Overall, the Group increased revenues by 65 % to SEK 327.5 (198.9) million compared with the previous year.

Accumulated revenue for January – October 2025 increased by 55 % to SEK 2,629.7 (1,693.2) million.
 

Revenues were distributed as follows:
 

Regions,MSEK	25-Oct	24-Oct	Change	YTD 2025	YTD 2024	Change
The Nordics	36.3	29.3	24%	270.3	243.3	11%
Central Europe	101.3	53.9	88%	758.9	448.3	69%
East Europe	34.4	34.5	0%	310.3	314.4	-1%
South & West Europe	57.8	37.0	56%	455.8	301.5	51%
The Baltics	13.0	10.1	29%	98.2	79.5	24%
North America	51.6	19.3	167%	433.6	153.3	183%
Asia-Pacific	28.1	5.8	384%	241.3	53.3	353%
Africa	2.3	1.7	35%	18.3	12.6	45%
Zinzino	324.8	191.6	70%	2586.7	1606.2	61%
Faun Pharma	2.7	7.3	-63%	43.0	87.0	-51%
Zinzino Group	327.5	198.9	65%	2629.7	1693.2	55%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

-Africa: South Africa

 

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Pictures for publication free of charge:
marketing@zinzino.com 

Certified Adviser:
DNB Carnegie Investment Bank AB (publ.)